Phase 2 results from a randomized controlled trial show very early mobilization of stroke patients within 24 hours of symptom onset significantly reduces rates of depression in this population.
Medscape Medical News
Much more than a motor illness, Parkinson's disease can have a significant impact on cognition, researchers emphasize.
Medscape Medical News
The first real-world study of Alzheimer's drugs shows that combination therapy with memantine and cholinesterase inhibitors slows the rate of cognitive and functional decline in the disease.
Medscape Medical News
Ventricular enlargement may be an objective and sensitive measure of neuropathological change associated with mild cognitive impairment and Alzheimer's disease, suitable to assess disease progression.
Brain
Review the emerging therapies for adults with glioblastoma.
Given the potential for breakthrough seizures and adverse events, how can clinicians address issues of concern about generic substitution of antiepileptic drugs?
Medscape Neurology & Neurosurgery
Nearly 40% of patients with MS may stop their prescribed regimen within 2-5 years of treatment initiation. What factors influence nonadherence? How can you improve long-term adherence?
The Medscape Journal of Medicine
Author(s): S T Retterer, K L Smith, C S Bjornsson, J N Turner, M S Isaacson and W Shain
Affiliation(s): Biosciences Division, Oak Ridge National Laboratory, Oak Ridge, TN, USA; Center for Nanophase Materials Sciences Division, Oak Ridge National Laboratory, Oak Ridge, TN, USA; Department of Biomedical Engineering, Cornell University, Ithaca, NY, USA; Wadsworth Center, New York State Department of Health, Albany, NY, USA; Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY, USA; State University of New York at Binghamton, Small Scale Systems Integration & Packaging, Binghamton, NY, USA; University of California at Santa Cruz, Baskin School of Engineering, Santa Cruz, CA, USA
Author(s): D Kacy Cullen, Ankur R Patel, John F Doorish, Douglas H Smith and Bryan J Pfister
Affiliation(s): Center for Brain Injury and Repair, Department of Neurosurgery, School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Department of Bioengineering, School of Engineering and Applied Science, University of Pennsylvania, Philadelphia, PA, USA; Doorish Ophthalmic Technologies, Inc., Brooklyn, NY, USA; Department of Biomedical Engineering, New Jersey Institute of Technology, University Heights, Newark, 07102, NJ, USA
Author(s): David E Snyder, Javier Echauz, David B Grimes and Brian Litt
Affiliation(s): NeuroVista Corporation, 100 4th Avenue North, Suite 600, Seattle, WA 98109, USA; JE Research, Inc., 170 Wentworth Terrace, Alpharetta, GA 30022, USA; Department of Neurology, University of Pennsylvania, 3400 Spruce St, Philadelphia, PA 19104, USA